FindTrial
Sign In

HPV DNA test in self-obtained vaginal sample(SOVAS) for institutional health screening program

Impact of SELf-obtained Vaginal Sample(SOVAS) for Detection of HPV DNA in An Institutional Health Screening Program (SELP-I)

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0005595
Enrollment
310
Registered
2020-11-13
Start date
2020-11-09
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : To investigate any increase of compliance to cervical cancer screening program, two devices to obtain self-vaginal sample were provided with usguideline. Then the self-obtained vagina

Sponsors

Korea Institute of Radiological & Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 310 women candidate for institutional health screening program

Exclusion criteria

Exclusion criteria: 1. Who has no sexual contact history 2. Currently on menstruation or any situation for sampling 3. Those who cannot read and follow the user's guideline 4. Those who is not applicable for study, which is determined by investigator

Design outcomes

Primary

MeasureTime frame
participation rate to screening program—

Secondary

MeasureTime frame
questionaire—

Countries

Korea, Republic of

Contacts

Public ContactMoon-Hong Kim

Korea Cancer Center Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026